Why do some people develop addiction and others do not? This session brings together research on genetic risk, family history, receptor pharmacology and biomarkers. Presenters show how pharmacogenomics can guide treatment choice and how molecular research is identifying new drug targets.
Topics include: pharmacogenetics of addiction, family history and inherited risk, alcohol and receptor pharmacology, molecular docking, biomarkers in opioid substitution treatment, epigenetics.